𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High-resolution analysis of alterations in medullary thyroid carcinoma genomes

✍ Scribed by Karin Flicker; Peter Ulz; Harald Höger; Petra Zeitlhofer; Oskar A. Haas; Annemarie Behmel; Wolfgang Buchinger; Christian Scheuba; Bruno Niederle; Roswitha Pfragner; Michael R. Speicher

Book ID
112101640
Publisher
John Wiley and Sons
Year
2011
Tongue
French
Weight
482 KB
Volume
131
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-resolution analysis of genomic alte
High-resolution analysis of genomic alteration on chromosome arm 8p in urothelial carcinoma
✍ Sarah V. Williams; Fiona M. Platt; Carolyn D. Hurst; Jo S. Aveyard; Claire F. Ta 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 675 KB

## Abstract Loss of chromosome arm 8p, sometimes in combination with amplification of proximal 8p, is found in urothelial carcinoma (UC) and other epithelial cancers and is associated with more advanced tumor stage. We carried out array comparative genomic hybridization on 174 UC and 33 UC cell lin

Absence of TP53 alterations in pheochrom
Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas
✍ Klaus K.-F. Herfarth; Mark R. Wick; Helen N. Marshall; Elaina Gartner; Sharon Lu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 2 views

The role of the TP53 gene in the development of inherited and sporadic pheochromocytomas and medullary thyroid carcinomas (MTC) has not been clarified because of conflicting reports and limitations in the assays used to detect mutations. To determine the frequency of TP53 alterations in these tumors

Overlapping high-resolution copy number
Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma
✍ Chian-Feng Chen; En-Chi Hsu; Kuen-Tyng Lin; Pang-Hsien Tu; Hung-Wei Chang; Chin- 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 605 KB

Recurrent cancer genome aberrations are indicators of residing crucial cancer genes. Although recent advances in genomic technologies have led to a global view of cancer genome aberrations, the identification of target genes and biomarkers from the aberrant loci remains difficult. To facilitate sear